Skip to main content
. 2013 Oct;347(1):100–116. doi: 10.1124/jpet.113.206896

Fig. 8.

Fig. 8.

Peptide #1 and MK-5046 activate MAPK in two different human BRS-3 cell lines: (A) Balb 3T3 or (B) NCI-N417. Above each panel are the representative Western blots of p42/44 MAPK phosphorylation in Balb/hBRS-3 cells. Results are shown of NCI-417 cells treated with 0.1 nM and 100 nM peptide #1 or MK-5046 and incubated for 3 minutes at 37°C. Each panel shows the mean ± S.E.M. from at least four experiments. The results are expressed as the percentage of the maximal concentration of peptide #1 (100 nM). *P < 0.05 versus 100 nM peptide #1.